全文获取类型
收费全文 | 485589篇 |
免费 | 49593篇 |
国内免费 | 3128篇 |
专业分类
耳鼻咽喉 | 9687篇 |
儿科学 | 16339篇 |
妇产科学 | 13847篇 |
基础医学 | 53007篇 |
口腔科学 | 10584篇 |
临床医学 | 53515篇 |
内科学 | 113479篇 |
皮肤病学 | 14479篇 |
神经病学 | 39102篇 |
特种医学 | 18915篇 |
外国民族医学 | 43篇 |
外科学 | 93156篇 |
综合类 | 8150篇 |
现状与发展 | 73篇 |
一般理论 | 169篇 |
预防医学 | 29103篇 |
眼科学 | 10909篇 |
药学 | 24072篇 |
中国医学 | 903篇 |
肿瘤学 | 28778篇 |
出版年
2023年 | 5353篇 |
2021年 | 6555篇 |
2020年 | 7936篇 |
2019年 | 5392篇 |
2018年 | 12279篇 |
2017年 | 10763篇 |
2016年 | 12282篇 |
2015年 | 12886篇 |
2014年 | 21409篇 |
2013年 | 24655篇 |
2012年 | 17797篇 |
2011年 | 18149篇 |
2010年 | 18129篇 |
2009年 | 21073篇 |
2008年 | 17198篇 |
2007年 | 16421篇 |
2006年 | 18474篇 |
2005年 | 15376篇 |
2004年 | 14099篇 |
2003年 | 12340篇 |
2002年 | 11766篇 |
2001年 | 17266篇 |
2000年 | 16753篇 |
1999年 | 14821篇 |
1998年 | 6941篇 |
1997年 | 6476篇 |
1996年 | 6167篇 |
1995年 | 5941篇 |
1994年 | 4440篇 |
1993年 | 3871篇 |
1992年 | 9767篇 |
1991年 | 9916篇 |
1990年 | 9377篇 |
1989年 | 9295篇 |
1988年 | 8366篇 |
1987年 | 7953篇 |
1986年 | 7645篇 |
1985年 | 7261篇 |
1984年 | 5351篇 |
1983年 | 4681篇 |
1982年 | 3050篇 |
1979年 | 4761篇 |
1978年 | 3581篇 |
1977年 | 3147篇 |
1975年 | 3128篇 |
1974年 | 3592篇 |
1973年 | 3607篇 |
1972年 | 3422篇 |
1971年 | 3152篇 |
1970年 | 3086篇 |
排序方式: 共有10000条查询结果,搜索用时 1 毫秒
31.
32.
33.
This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized
by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment
and the belief that PE is a normal part of aging, that it has no effective treatment, or that it will resolve itself, few
men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods;
desensitizing drugs; off-label use of antidepressants, phosphodiesterase type 5 inhibitors, or à-blockers), the majority of
men with PE are not satisfied with their results. New pharmacologic drugs develped specifically for the treatment of PE are
undergoing evaluation in clinical trials. For example, recent clinical research studies have revealed on-demand administration
of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and
satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction
with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral
therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development
may provide benefits over those available. 相似文献
34.
Adriana B Campaner Alessandro Scapinelli Ruy O Machado Roberto E Dos Santos Geni W Beznos Tsutomu Aoki 《Gynecological endocrinology》2006,22(7):395-398
We report a case of a prepubertal girl with juvenile primary hypothyroidism presenting as ovarian cysts and precocious puberty. The 7-year-old female was referred to our clinic because of a pelvic/abdominal mass and vaginal bleeding. Besides these findings, on physical examination we noticed the thyroid gland globally increased and the presence of secondary sexual characteristics. Based upon the clinical profile and investigations, the patient was diagnosed with juvenile primary hypothyroidism due to autoimmune thyroiditis. The cysts and precocious puberty resolved spontaneously after the simple replacement of thyroid hormone. It is important to bear in mind hypothyroidism in cases of girls presenting ovarian cysts and precocious puberty in order to avoid unnecessary surgery on the ovaries. 相似文献
35.
36.
Elhaji Youssef A.; Stoica Ileana; Dennis Sheldon; Purisima Enrico O.; Lumbroso Rose; Beitel Lenore K.; Trifiro Mark A. 《Human molecular genetics》2006,15(9):1561
Human Molecular Genetics (2006) 15, 921931; 相似文献
37.
Raoul Orvieto Irina Zagatsky Vered Yulzari-Roll Antonio La Marca Benjamin Fisch 《Gynecological endocrinology》2006,22(8):437-440
BACKGROUND: To investigate the degree of systemic inflammation, as reflected by serum C-reactive protein (CRP) levels, associated with controlled ovarian hyperstimulation (COH) with human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone (GnRH) agonist for the induction of final follicular maturation. DESIGN: Prospective, observational study. SETTING: An in vitro fertilization (IVF) unit of an academic medical center. PATIENTS: Twenty-four women undergoing COH and IVF with the flexible GnRH antagonist protocol were prospectively assigned to receive hCG or GnRH agonist for the induction of final follicular maturation. METHODS: Blood was drawn three times during COH for measurement of sex-steroid and CRP levels: the day on which adequate suppression was obtained (Day-0); the day of or prior to administration of hCG (Day-hCG); and (3) the day of ovum pick-up (Day-OPU). Levels were compared among the three time points in the two groups. RESULTS: No between-group differences were observed in terms of patient age, gonadotropin dosage, duration of stimulation or number of oocytes retrieved. Serum CRP levels were significantly higher on Day-OPU than on Day-hCG and Day-0, but the difference was significant only in the hCG group (p<0.03 for both). The percentage change in CRP levels after hCG administration (Day-OPU vs. Day-hCG) (96%) was higher than that after GnRH administration (23%). CONCLUSION: Administration of GnRH agonist in patients undergoing COH for IVF yields a lesser degree of systemic inflammation, as reflected by CRP levels, than hCG. 相似文献
38.
Caterina Proto Daniela Romualdi Rosa Maria Cento Rosario S Spada Giuseppina Di Mento Raffaele Ferri Antonio Lanzone 《Gynecological endocrinology》2006,22(4):213-218
BACKGROUND: In the central nervous system, several neuropeptides are believed to be involved in the pathophysiology of Alzheimer's disease (AD). Indeed, previous studies have documented that glucagon-like peptide 1 (GLP-1) possesses neurotropic properties and can reduce amyloid-beta peptide levels in the brain in vivo. Moreover, the concentrations of neuropeptide Y (NPY) seem to be altered in the cerebrospinal fluid of patients with AD and in subjects with major depression. Finally, among the modifications induced by aging, a dysregulation of the ghrelin-growth hormone (GH) system has been reported. METHODS: We investigated the plasma concentrations of these neuropeptides in 14 subjects with AD. Data obtained from these patients were compared with data from an age- and weight-matched healthy group. RESULTS: No significant differences were found between the two groups in relation to plasma levels of GLP-1, NPY, ghrelin and GH. Peripheral NPY concentrations were positively correlated with ghrelin levels in both groups, and with plasma GLP-1 concentration only in controls. CONCLUSION: On the basis of our results, peripheral levels of these neuropeptides seem not to serve as biochemical markers of AD. 相似文献
39.
Bruno Ferrari Antonio Pezzuto Lorenzo Barusi Francesco Coppola 《Gynecological endocrinology》2006,22(6):289-296
The aim of the present study was to investigate the effect of gonadotropin-releasing hormone (GnRH) antagonists (GnRH-ant) on follicular fluid (FF) insulin-like growth factor-I (IGF-I) and FF vascular endothelial growth factor (VEGF) levels. Sixty women undergoing assisted reproduction were randomized and assigned to two different GnRH analog regimens: GnRH agonist (GnRH-a) and GnRH-ant. FF VEGF and FF IGF-I concentrations were significantly increased in the patients treated with GnRH-ant (p < 0.001). In the same patients we observed a statistically significant reduction in serum luteinizing hormone (LH) and estradiol (E2) levels (p < 0.001 and p < 0.05, respectively), FF E2 and FF androstenedione levels (p < 0.05 and p < 0.001, respectively), as well as a reduction in the number of pregnancies although this was not statistically significant. In the GnRH-ant group, FF VEGF levels were positively correlated with FF IGF-I levels, and both were negatively correlated with serum LH levels. The increase in FF IGF-I and FF VEGF levels in women treated with GnRH-ant could be explained by a deleterious follicular environment in response to profound suppression of LH and E2 levels. 相似文献
40.